Christopher Liu

Analyst

Lucid Capital Markets

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher Liu

Christopher Liu is recorded as Analyst at Lucid Capital Markets. Christopher Liu has spoken on 3 earnings calls and 1 other investor event across 3 companies, most recently for Innate Pharma SA on May 13, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Lucid Capital Markets

Analyst

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Innate Pharma SA

IPHA

2 appearances Latest appearance 2026-05-13

View calls and events

Relmada Therapeutics, Inc.

RLMD

1 appearance Latest appearance 2026-05-12

View calls and events

Cardiff Oncology, Inc.

CRDF

1 appearance Latest appearance 2026-01-27

View calls and events

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call Earnings conference call (announced in 6-K) Innate Pharma SA (IPHA)
2026-05-13
Earnings call Relmada Therapeutics, Inc. Q1 FY2026 Earnings Call Relmada Therapeutics, Inc. (RLMD)
2026-05-12
Earnings call Innate Pharma SA Q1 FY2026 Earnings Call Innate Pharma SA (IPHA)
2026-03-26
Conference Cardiff Oncology, Inc. Conference Call Cardiff Oncology, Inc. (CRDF)
2026-01-27